JAGSNPHARM Quarterly Results, Profit & Loss, Balance Sheet (JAGSNPHARM)

JAGSNPHARM quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • JAGSNPHARM Financials
  • JAGSNPHARM Shareholding Pattern
  • JAGSNPHARM Earnings Documents
  • JAGSNPHARM Announcements
  • JAGSNPHARM Corporate Actions
  • JAGSNPHARM Bulk, Block & Insider Deals
  • JAGSNPHARM Delivery Data
  • JAGSNPHARM Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Jagsonpal Pharmaceuticals Ltd reported sales of ₹96 Cr, operating profit of ₹17 Cr (OPM 18%) and net profit of ₹12 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

JAGSNPHARM quarterly results (₹ Cr)
MetricSep 2026
Sales96
Expenses79
Operating Profit17
OPM18%
Other Income2
Interest0
Depreciation2
Profit before tax16
Tax25%
Net Profit12
EPS in Rs1.86
  • JAGSNPHARM Shareholding Pattern
  • JAGSNPHARM Earnings Concalls
  • JAGSNPHARM Growth Catalysts
  • JAGSNPHARM Corporate Actions
  • JAGSNPHARM Announcements
  • JAGSNPHARM Results & Documents
  • JAGSNPHARM Bulk & Block Deals
  • JAGSNPHARM Delivery Data